We are live on
!
Find out more
DCM
Driehaus Capital Management Portfolio holdings
AUM
$13.6B
1-Year Est. Return
173.98%
This Fund
S&P 500
This Quarter
Est. Return
+22.75%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$8.3B
AUM Growth
+$608M
(+7.9%)
Cap. Flow
-$511M
Cap. Flow
% of AUM
-6.15%
Top 10 Holdings %
Top 10 Hldgs %
19.18%
Holding
485
New
95
Increased
116
Reduced
139
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$56.3M |
| 2 |
TSMC
TSM
|
+$47.6M |
| 3 |
Wingstop
WING
|
+$41.3M |
| 4 |
Western Alliance Bancorporation
WAL
|
+$39.5M |
| 5 |
Camtek
CAMT
|
+$38.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axcelis
ACLS
|
+$78.8M |
| 2 |
Kinsale Capital Group
KNSL
|
+$71.8M |
| 3 |
Celsius Holdings
CELH
|
+$68.7M |
| 4 |
Procore
PCOR
|
+$62.2M |
| 5 |
Trip.com Group
TCOM
|
+$50M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Industrials | 21.11% |
| 3 | Healthcare | 20.21% |
| 4 | Consumer Discretionary | 8.72% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TERN
251
DELISTED
Terns Pharmaceuticals
TERN
| $7.33M | 0.09% |
1,130,052
-487,868
| -30% | -$2.58M |
|
252
Broadcom
AVGO
$1.87T
| $7.33M | 0.09% |
65,670
+55,860
| +569% | +$5.29M |
|
253
Ryan Specialty Holdings
RYAN
$5.65B
| $7.32M | 0.09% |
170,186
-145,989
| -46% | -$6.58M |
|
254
Celestica
CLS
$39.3B
| $7.3M | 0.09% |
249,456
-790,644
| -76% | -$21M |
|
|
DAWN
255
DELISTED
Day One Biopharmaceuticals
DAWN
| $7.06M | 0.09% |
483,239
-5,079
| -1% | -$61.6K |
|
256
GXO Logistics
GXO
$5.82B
| $7.05M | 0.08% |
115,221
-180,286
| -61% | -$10.1M |
|
257
Liberty Energy
LBRT
$3.1B
| $6.76M | 0.08% |
+372,886
| New | +$7.08M |
|
258
Relay Therapeutics
RLAY
$4.09B
| $6.53M | 0.08% |
593,002
| – | – |
|
259
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.6B
| $6.19M | 0.07% |
111,744
-56,050
| -33% | -$2.89M |
|
260
ASE Group
ASX
$80.7B
| $6.01M | 0.07% |
+638,384
| New | +$5.29M |
|
|
IMGN
261
DELISTED
Immunogen Inc
IMGN
| $5.81M | 0.07% |
195,980
-1,244,072
| -86% | -$24.8M |
|
|
BELFB
262
Bel Fuse Inc Class B
BELFB
$3.91B
| $5.77M | 0.07% |
+86,372
| New | +$4.63M |
|
|
SCRM
263
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
| $5.57M | 0.07% |
525,785
| – | – |
|
264
LeMaitre Vascular
LMAT
$2.37B
| $5.51M | 0.07% |
96,988
-23,903
| -20% | -$1.25M |
|
265
Advanced Micro Devices
AMD
$790B
| $5.25M | 0.06% |
+35,598
| New | +$4.2M |
|
|
HYAC
266
DELISTED
Haymaker Acquisition Corp 4
HYAC
| $5.13M | 0.06% |
500,000
| – | – |
|
|
SWTX
267
DELISTED
SpringWorks Therapeutics
SWTX
| $4.99M | 0.06% |
136,624
-397,721
| -74% | -$10.4M |
|
268
Aehr Test Systems
AEHR
$2.99B
| $4.91M | 0.06% |
185,140
-1,266,206
| -87% | -$36.9M |
|
|
PHLT
269
DELISTED
Performant Healthcare Inc
PHLT
| $4.63M | 0.06% |
1,481,322
-21,558
| -1% | -$56.5K |
|
270
Protagonist Therapeutics
PTGX
$8.51B
| $4.56M | 0.05% |
+198,689
| New | +$3.48M |
|
271
Perion Network
PERI
$382M
| $4.52M | 0.05% |
146,478
-467,013
| -76% | -$13.3M |
|
272
Dr. Reddy's Laboratories
RDY
$10.1B
| $4.37M | 0.05% |
314,100
-439,420
| -58% | -$5.87M |
|
273
Laureate Education
LAUR
$5.18B
| $4.34M | 0.05% |
+316,413
| New | +$4.34M |
|
274
Edgewise Therapeutics
EWTX
$4.13B
| $4.32M | 0.05% |
+395,069
| New | +$2.77M |
|
275
Microsoft
MSFT
$3.62T
| $4.11M | 0.05% |
10,927
+889
| +9% | +$316K |
|
Similar funds
CC
PMAM
SA
PSCM
WHG
AA
WA
SAM
Driehaus Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Driehaus Capital Management held 485 positions worth $8.3B, up 7.9% from $7.69B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Driehaus Capital Management withdrew a net $511M in Q4 2023, closing 106 positions and reducing 139 holdings. Its most notable exit was Axcelis, an estimated $78.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Driehaus Capital Management opened a new position in Pinduoduo worth $67.9M.
- Driehaus Capital Management's largest Q4 2023 buy was Pinduoduo: 463,956 shares worth $67.9M.
- Driehaus Capital Management added most to TSMC in Q4 2023, an estimated $47.6M increase.
- Driehaus Capital Management's biggest Q4 2023 reduction was Kinsale Capital Group, cutting an estimated $71.8M.
- Driehaus Capital Management fully exited Axcelis in Q4 2023, selling an estimated $78.8M.
- Driehaus Capital Management's ten largest holdings make up 19% of its $8.3B portfolio in Q4 2023.
- Driehaus Capital Management opened 95 new positions and closed 106 in Q4 2023.
- Driehaus Capital Management's portfolio value rose 7.9% quarter-over-quarter to $8.3B.
Based on Driehaus Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.